JOHN HOPE FRANKLIN CENTER

JOHN HOPE FRANKLIN CENTER logo
🇺🇸United States
Ownership
Private
Established
1838-01-01
Employees
5K
Market Cap
-
Website
http://www.duke.edu
Clinical Trials
Related News

Quetiapine in Social Anxiety Disorder

Phase 2
Completed
Conditions
Social Anxiety Disorder
First Posted Date
2005-09-22
Last Posted Date
2006-12-19
Lead Sponsor
Duke University
Target Recruit Count
15
Registration Number
NCT00215254
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

Modafinil for Atypical Depression

Phase 2
Completed
Conditions
Atypical Depression
First Posted Date
2005-09-22
Last Posted Date
2013-06-19
Lead Sponsor
Duke University
Target Recruit Count
65
Registration Number
NCT00215176

Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder

Phase 2
Completed
Conditions
OCD
Interventions
Drug: Placebo ( sugar pill)
Drug: escitalopram
First Posted Date
2005-09-22
Last Posted Date
2014-07-23
Lead Sponsor
Duke University
Target Recruit Count
14
Registration Number
NCT00215137
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

Risperidone Augmentation for PTSD

Phase 2
Completed
Conditions
Post-Traumatic Stress Disorder
First Posted Date
2005-09-22
Last Posted Date
2014-09-22
Lead Sponsor
Duke University
Target Recruit Count
80
Registration Number
NCT00215241
Locations
🇺🇸

Emory University Medical Center, Atlanta, Georgia, United States

🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Effects of Duloxetine vs. Escitalopram on Heart Rate Variability in Depression

Phase 2
Completed
Conditions
Major Depressive Disorder
First Posted Date
2005-09-22
Last Posted Date
2014-07-21
Lead Sponsor
Duke University
Target Recruit Count
26
Registration Number
NCT00215228
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence

Phase 4
Completed
Conditions
Schizophrenia
Schizoaffective Disorder
First Posted Date
2005-09-22
Last Posted Date
2014-09-22
Lead Sponsor
Duke University
Target Recruit Count
64
Registration Number
NCT00215579
Locations
🇺🇸

John Umstead Hospital, Butner, North Carolina, United States

DBT Compared to I/GDC for the Treatment of Opiate Addiction in Emotionally Dysregulated Patients. - 1

First Posted Date
2005-09-22
Last Posted Date
2014-08-01
Lead Sponsor
Duke University
Target Recruit Count
39
Registration Number
NCT00218595
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

Geodon for the Treatment of Refractory Social Anxiety Disorder

Phase 2
Completed
Conditions
Social Anxiety Disorder
Interventions
Drug: Ziprasidone
Drug: Sertraline
First Posted Date
2005-09-22
Last Posted Date
2014-10-31
Lead Sponsor
Duke University
Target Recruit Count
51
Registration Number
NCT00215150
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

Promoting Postpartum Weight Loss in Overweight Women

Not Applicable
Completed
Conditions
Obesity
Interventions
Behavioral: moderate exercise and healthy, low-fat diet
First Posted Date
2005-09-21
Last Posted Date
2014-07-15
Lead Sponsor
Duke University
Target Recruit Count
450
Registration Number
NCT00212251
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

Interventions to Improve Hypertension Control and Reduce Cardiovascular Disease Risk

First Posted Date
2005-09-20
Last Posted Date
2015-10-14
Lead Sponsor
Duke University
Target Recruit Count
574
Registration Number
NCT00201136
Locations
🇺🇸

Duke University, Durham, North Carolina, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy